1.19

0.82% -0.03

Theratechnologies Inc (THTX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Perché THTX Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$1.22

Aprire:

$1.21

Volume 24 ore:

7,747

Relative Volume:

0.23

Capitalizzazione di mercato:

$55.64M

Reddito:

$81.76M

Utile/perdita netta:

$-23.96M

Rapporto P/E:

-0.9754

EPS:

-1.22

Flusso di cassa netto:

$-7.50M

1 W Prestazione:

+0.00%

1M Prestazione:

-11.03%

6M Prestazione:

-9.02%

1 anno Prestazione:

-12.95%

Intervallo 1D:

$1.1949

$1.21

Intervallo di 1 settimana:

$1.16

$1.22

Portata 52W:

$1.08

$2.58

Theratechnologies Inc Stock (THTX) Company Profile

Nome

Theratechnologies Inc

Settore

Healthcare (1195)

Industria

Biotechnology (683)

Telefono

Indirizzo

Dipendente

103

Cinguettio

@Theratech_

Prossima data di guadagno

2024-10-10

Ultimi documenti SEC

THTX's Discussions on Twitter

Confronta THTX con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
THTX	1.21	55.64M	81.76M	-23.96M	-7.50M	-1.22
VRTX	449.44	115.43B	10.63B	-479.80M	-1.35B	13.33
REGN	746.00	82.04B	13.85B	4.65B	3.32B	35.06
ARGX	596.25	35.30B	1.86B	-40.29M	-1.28B	-4.16
ALNY	247.03	32.04B	2.09B	-332.26M	16.06M	-4.14
BNTX	107.90	24.89B	3.30B	-501.07M	1.03B	11.54

Theratechnologies Inc Stock (THTX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2022-11-17	Iniziato	Cantor Fitzgerald	Overweight
2021-07-29	Downgrade	Canaccord Genuity	Buy → Hold

Theratechnologies Inc Borsa (THTX) Ultime notizie

Nov 15, 2024

Theratechnologies Inc. (NASDAQ:THTX) Short Interest Up 26.8% in October - MarketBeat

Nov 15, 2024

Nov 14, 2024

Theratechnologies (TSE:TH) Share Price Passes Above Fifty Day Moving AverageTime to Sell? - MarketBeat

Nov 14, 2024

Nov 03, 2024

Net Present Value Model: Theratechnologies Inc’s Sudocetaxel Zendusortide - GlobalData

Nov 03, 2024

Oct 29, 2024

Theratechnologies (TSE:TH) Stock Passes Below Fifty Day Moving AverageTime to Sell? - MarketBeat

Oct 29, 2024

Oct 25, 2024

Short Interest in Theratechnologies Inc. (NASDAQ:THTX) Rises By 226.0% - MarketBeat

Oct 25, 2024

Oct 24, 2024

Closing Bell: Theratechnologies Down On Monday (TH) - Barchart

Oct 24, 2024

Oct 22, 2024

THTX upgraded at Research Capital - Cantech Letter

Oct 22, 2024

Oct 19, 2024

Theratechnologies (TSE:TH) Stock Price Crosses Above 50 Day Moving AverageHere's Why - MarketBeat

Oct 19, 2024

Oct 18, 2024

Theratechnologies IDWeek Presentations Highlight the Impact of Excess Visceral Abdominal Fat (EVAF) on Cardiovascular Disease (CVD) Risk in People with HIV - The Manila Times

Oct 18, 2024

Oct 17, 2024

Theratechnologies reports use of HIV drug in severe cases - Investing.com

Oct 17, 2024

Theratechnologies reports use of HIV drug in severe cases By Investing.com - Investing.com South Africa

Oct 17, 2024

Theratechnologies Unveils Study Design and Baseline Characteristics of PROMISE-US Trial of Ibalizumab in Heavily Treatment-Experienced People with HIV and Multidrug Resistance - GlobeNewswire

Oct 17, 2024

Oct 15, 2024

Theratechnologies Inc. Forecasted to Earn FY2024 Earnings of $0.04 Per Share (NASDAQ:THTX) - Defense World

Oct 15, 2024

Oct 14, 2024

Cantor Fitzgerald Weighs in on Theratechnologies Inc.'s FY2024 Earnings (NASDAQ:THTX) - MarketBeat

Oct 14, 2024

Oct 11, 2024

Earnings call: Theratechnologies reports Q3 profit, raises EBITDA guidance - Investing.com

Oct 11, 2024

Theratechnologies (NASDAQ:THTX) Releases Quarterly Earnings Results, Beats Expectations By $0.03 EPS - MarketBeat

Oct 11, 2024

Theratechnologies Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Oct 11, 2024

Theratechnologies (TSE:TH) Stock Passes Above 50 Day Moving AverageWhat's Next? - MarketBeat

Oct 11, 2024